Sterling Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20K | Buy |
1,170
+865
| +284% | +$14.8K | ﹤0.01% | 1799 |
|
|
2025
Q1 | $19.5K | Sell |
305
-1,159
| -79% | -$74K | ﹤0.01% | 1664 |
|
|
2024
Q4 | $178K | Sell |
1,464
-190
| -11% | -$23.1K | ﹤0.01% | 1302 |
|
|
2024
Q3 | $207K | Buy |
+1,654
| New | +$207K | ﹤0.01% | 1258 |
|
|
2017
Q1 | – | Sell |
-9,205
| Closed | -$252K | – | 1006 |
|
|
2016
Q4 | $252K | Buy |
+9,205
| New | +$252K | ﹤0.01% | 869 |
|
|
2016
Q1 | – | Sell |
-5,760
| Closed | -$222K | – | 981 |
|
|
2015
Q4 | $222K | Sell |
5,760
-1,589
| -22% | -$61.2K | ﹤0.01% | 921 |
|
|
2015
Q3 | $236K | Sell |
7,349
-4,651
| -39% | -$149K | ﹤0.01% | 899 |
|
|
2015
Q2 | $365K | Sell |
12,000
-4,276
| -26% | -$130K | ﹤0.01% | 769 |
|
|
2015
Q1 | $216K | Sell |
16,276
-26,426
| -62% | -$351K | ﹤0.01% | 834 |
|
|
2014
Q4 | $618K | Buy |
42,702
+5,322
| +14% | +$77K | 0.01% | 736 |
|
|
2014
Q3 | $789K | Buy |
+37,380
| New | +$789K | 0.01% | 673 |
|
|
2014
Q2 | – | Sell |
-15,438
| Closed | -$371K | – | 932 |
|
|
2014
Q1 | $371K | Buy |
+15,438
| New | +$371K | ﹤0.01% | 823 |
|